Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence

被引:0
|
作者
Rosa Escudero-Sanchez
Antonio Ramos-Martínez
Antonio F. Caballero-Bermejo
Beatriz Díaz-Pollán
Guillermo Ruiz-Carrascoso
María Olmedo Samperio
Patricia Muñoz García
Paloma Merino Amador
Fernando González Romo
Oriol Martín Segarra
Gema Navarro Jiménez
Laura del Campo Albendea
Alfonso Muriel García
Javier Cobo
机构
[1] Ramon y Cajal University Hospital,Infectious Disease Department
[2] Instituto de Salud Carlos III (IRYCIS),Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC)
[3] Instituto de Salud Carlos III,Internal Medicine Department
[4] University Hospital Puerta de Hierro-Majadahonda,Pharmacology Department
[5] University Hospital Puerta de Hierro-Majadahonda,Infectious Diseases Unit, Internal Medicine Department
[6] La Paz University Hospital,Microbiology Department
[7] La Paz Institute for Health Research (IdiPAZ),Microbiology and Infectious Disease Department
[8] La Paz University Hospital,Microbiology Department
[9] Gregorio Marañón University Hospital,Infectious Disease Department
[10] Clínico San Carlos University Hospital,Biostatistics Unit
[11] Fundación Alcorcon University Hospital,undefined
[12] University Hospital Ramon y Cajal,undefined
[13] Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP),undefined
[14] Universidad de Alcalá,undefined
来源
European Journal of Clinical Microbiology & Infectious Diseases | 2024年 / 43卷
关键词
Bezlotoxumab; infection; Recurrence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:533 / 540
页数:7
相关论文
共 50 条
  • [31] Real-world effectiveness of fidaxomicin in patients at high risk of Clostridioides difficile recurrence
    Colwell, Benjamin
    Aguilar, Jennifer
    Hughes, Frances
    Goriacko, Pavel
    Chen, Victor
    Chang, Mei
    Bartash, Rachel
    Guo, Yi
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2024, 4 (01):
  • [32] Efficacy of bezlotoxumab to prevent recurrent Clostridioides difficile infection (CDI) in patients with multiple prior recurrent CDI
    Skinner, Andrew M.
    Tan, Xing
    Westman, Colin
    Birris, Thomas
    Drwiega, Emily N.
    Wang, Michael S.
    Johnson, Stuart
    ANAEROBE, 2023, 84
  • [33] Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study
    Polivkova, Sylvia
    Krutova, Marcela
    Capek, Vaclav
    Sykorova, Blanka
    Benes, Jiri
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 103 : 226 - 233
  • [34] ASSOCIATION OF FECAL CALPROTECTIN AND RECURRENCE OF CLOSTRIDIOIDES DIFFICILE INFECTION IN HOSPITALIZED PATIENTS
    Valdez-Hernandez, Pedro
    Murra, Claudia P. Alarcon
    Robredo, Alfonso
    Luna, Mario Pelaez
    Uscanga, Luis
    Calleros, Jorge Hernandez
    GASTROENTEROLOGY, 2020, 158 (06) : S988 - S989
  • [35] Risk of rehospitalization due to Clostridioides difficile infection among hospitalized patients with Clostridioides difficile: a cohort study
    Drwiega, Emily N.
    Johnson, Stuart
    Danziger, Larry H.
    Skinner, Andrew M.
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2024, 45 (11) : 1293 - 1299
  • [36] CARDIAC EVENTS IN PATIENTS WITH HEART FAILURE RECEIVING BEZLOTOXUMAB FOR THE PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION - A MULTICENTER STUDY
    Chaar, Abdelkader
    Rizwan, Rabia
    Sehgal, Kanika
    Damianos, John A.
    Nawaz, Ahmad
    Feuerstadt, Paul
    GASTROENTEROLOGY, 2023, 164 (06) : S698 - S698
  • [37] Infusion of Bezlotoxumab at the End of an Antibiotic Treatment Course for Prevention of Recurrent Clostridioides difficile Infection
    Westman, Colin
    Birris, Thomas
    Skinner, Andrew M.
    Johnson, Stuart
    Wang, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S82 - S82
  • [38] Recurrence of Clostridioides difficile infection and mortality in older inpatients
    Remelli, Francesca
    Mattioli, Irene
    Govoni, Benedetta
    Zurlo, Amedeo
    De Giorgio, Roberto
    Volpato, Stefano
    Cultrera, Rosario
    EUROPEAN GERIATRIC MEDICINE, 2024, 15 (03) : 743 - 751
  • [39] Risk of Clostridioides difficile infection in patients with inflammatory bowel disease
    Martinez Lozano, H.
    Saralegui Gonzalez, P.
    Fueyo Pelaez, P. R.
    Garcia Garcia, A.
    Miranda-Bautista, J.
    Reigadas Ramirez, E.
    Alcala Hernandez, L.
    Munoz Garcia, P.
    Marin-Jimenez, I.
    Menchen, L.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2044 - I2044
  • [40] Clostridioides difficile infection and recurrence in cancer patients (CIRCA): A multicentre, international study
    Puerta-Alcalde, Pedro
    O'Keefe, Jessica
    Woolstencroft, Rachel
    Kaul, Shipraa
    Lopez, Nestor
    Cronin, Katie
    Lim, Andrew
    Garcia-Pouton, Nicole
    Alvarez, Miriam
    Chee, Lynette
    Espasa, Mateu
    Grafia, Ignacio
    Suarez-Lledo, Maria
    Smibert, Olivia
    Garcia-Vidal, Carolina
    Slavin, Monica A.
    Yong, Michelle K.
    Soriano, Alex
    Worth, Leon J.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 153